Integrilin (eptifibatide) supply shortage
Submitted by Anonymous (not verified) on 17 January 2024 - 9:22
Integrilin (eptifibatide) supply shortage
Integrilin (eptifibatide) supply shortage
Quality of medicines questions and answers: Part 2
Human medicines: highlights of 2023
Human medicines highlights 2023
Big Data Steering Group (BDSG): 2023 report
Conversations on Cancer: Transforming Patient Lives by Therapeutic and Regulatory Innovations, European Medicines Agency, Amsterdam, the Netherlands, from 1 February 2024, 15:30 (CET) to 1 February 2024, 17:00 (CET)
Human medicines European public assessment report (EPAR): Intrarosa, prasterone, Date of authorisation: 08/01/2018, Revision: 7, Status: Authorised
Applications for new human medicines under evaluation: January 2024
Guidance on paediatric submissions
Guidance on paediatric submissions